G

Glenmark Pharmaceuticals Ltd
NSE:GLENMARK

Watchlist Manager
Glenmark Pharmaceuticals Ltd
NSE:GLENMARK
Watchlist
Price: 1 547.45 INR -0.2%
Market Cap: 436.7B INR
Have any thoughts about
Glenmark Pharmaceuticals Ltd?
Write Note

Intrinsic Value

The intrinsic value of one GLENMARK stock under the Base Case scenario is 1 053.31 INR. Compared to the current market price of 1 547.45 INR, Glenmark Pharmaceuticals Ltd is Overvalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLENMARK Intrinsic Value
1 053.31 INR
Overvaluation 32%
Intrinsic Value
Price
G
Worst Case
Base Case
Best Case

Valuation History
Glenmark Pharmaceuticals Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for GLENMARK cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about GLENMARK?
Bearish
Neutral
Bullish

Fundamental Analysis

1 547.45 INR
-0.2%
-0.2%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Glenmark Pharmaceuticals Ltd
IN
Pharmaceuticals
Market Cap
436.7B INR
IPO
Dec 10, 1999
Employees
13 390
India
Market Cap
436.7B INR
Industry
Pharmaceuticals
IPO
Dec 10, 1999
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Glenmark Pharmaceuticals Ltd

Provide an overview of the primary business activities
of Glenmark Pharmaceuticals Ltd.

What unique competitive advantages
does Glenmark Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does Glenmark Pharmaceuticals Ltd face in the near future?

Has there been any significant insider trading activity
in Glenmark Pharmaceuticals Ltd recently?

Summarize the latest earnings call
of Glenmark Pharmaceuticals Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Glenmark Pharmaceuticals Ltd.

Provide P/S
for Glenmark Pharmaceuticals Ltd.

Provide P/E
for Glenmark Pharmaceuticals Ltd.

Provide P/OCF
for Glenmark Pharmaceuticals Ltd.

Provide P/FCFE
for Glenmark Pharmaceuticals Ltd.

Provide P/B
for Glenmark Pharmaceuticals Ltd.

Provide EV/S
for Glenmark Pharmaceuticals Ltd.

Provide EV/GP
for Glenmark Pharmaceuticals Ltd.

Provide EV/EBITDA
for Glenmark Pharmaceuticals Ltd.

Provide EV/EBIT
for Glenmark Pharmaceuticals Ltd.

Provide EV/OCF
for Glenmark Pharmaceuticals Ltd.

Provide EV/FCFF
for Glenmark Pharmaceuticals Ltd.

Provide EV/IC
for Glenmark Pharmaceuticals Ltd.

Show me price targets
for Glenmark Pharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for Glenmark Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for Glenmark Pharmaceuticals Ltd?

What are the Net Income projections
for Glenmark Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for Glenmark Pharmaceuticals Ltd?

What are the EPS projections
for Glenmark Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for Glenmark Pharmaceuticals Ltd?

What are the EBIT projections
for Glenmark Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for Glenmark Pharmaceuticals Ltd?

Compare the revenue forecasts
for Glenmark Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Glenmark Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Glenmark Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Glenmark Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of Glenmark Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Glenmark Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of Glenmark Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for Glenmark Pharmaceuticals Ltd.

Provide ROE
for Glenmark Pharmaceuticals Ltd.

Provide ROA
for Glenmark Pharmaceuticals Ltd.

Provide ROIC
for Glenmark Pharmaceuticals Ltd.

Provide ROCE
for Glenmark Pharmaceuticals Ltd.

Provide Gross Margin
for Glenmark Pharmaceuticals Ltd.

Provide Operating Margin
for Glenmark Pharmaceuticals Ltd.

Provide Net Margin
for Glenmark Pharmaceuticals Ltd.

Provide FCF Margin
for Glenmark Pharmaceuticals Ltd.

Show all solvency ratios
for Glenmark Pharmaceuticals Ltd.

Provide D/E Ratio
for Glenmark Pharmaceuticals Ltd.

Provide D/A Ratio
for Glenmark Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for Glenmark Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for Glenmark Pharmaceuticals Ltd.

Provide Quick Ratio
for Glenmark Pharmaceuticals Ltd.

Provide Current Ratio
for Glenmark Pharmaceuticals Ltd.

Provide Cash Ratio
for Glenmark Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for Glenmark Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for Glenmark Pharmaceuticals Ltd?

What is the current Free Cash Flow
of Glenmark Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Glenmark Pharmaceuticals Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Glenmark Pharmaceuticals Ltd

Current Assets 90.3B
Cash & Short-Term Investments 20.4B
Receivables 28.6B
Other Current Assets 41.3B
Non-Current Assets 62B
Long-Term Investments 1.1B
PP&E 35.5B
Intangibles 13.5B
Other Non-Current Assets 11.9B
Current Liabilities 61.8B
Accounts Payable 23.6B
Other Current Liabilities 38.2B
Non-Current Liabilities 6B
Long-Term Debt 1.4B
Other Non-Current Liabilities 4.6B
Efficiency

Earnings Waterfall
Glenmark Pharmaceuticals Ltd

Revenue
122.5B INR
Cost of Revenue
-42.1B INR
Gross Profit
80.4B INR
Operating Expenses
-70.9B INR
Operating Income
9.5B INR
Other Expenses
-18.2B INR
Net Income
-8.8B INR

Free Cash Flow Analysis
Glenmark Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GLENMARK Profitability Score
Profitability Due Diligence

Glenmark Pharmaceuticals Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive Operating Income
37/100
Profitability
Score

Glenmark Pharmaceuticals Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

GLENMARK Solvency Score
Solvency Due Diligence

Glenmark Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Long-Term Solvency
67/100
Solvency
Score

Glenmark Pharmaceuticals Ltd's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLENMARK Price Targets Summary
Glenmark Pharmaceuticals Ltd

Wall Street analysts forecast GLENMARK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLENMARK is 1 645.95 INR with a low forecast of 575.7 INR and a high forecast of 2 137.8 INR.

Lowest
Price Target
575.7 INR
63% Downside
Average
Price Target
1 645.95 INR
6% Upside
Highest
Price Target
2 137.8 INR
38% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GLENMARK?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GLENMARK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GLENMARK Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one GLENMARK stock?

The intrinsic value of one GLENMARK stock under the Base Case scenario is 1 053.31 INR.

Is GLENMARK stock undervalued or overvalued?

Compared to the current market price of 1 547.45 INR, Glenmark Pharmaceuticals Ltd is Overvalued by 32%.

Back to Top